Pure Global

Declarite 500 mg I.V. Lyophilized Powder and Solvent for Preparing Solution for Infusion, 1 vial + 1 solvent ampoule - Turkey License 64cf9bcffd9cc09db16382f1bf364928

Access comprehensive regulatory information for Declarite 500 mg I.V. Lyophilized Powder and Solvent for Preparing Solution for Infusion, 1 vial + 1 solvent ampoule in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number 64cf9bcffd9cc09db16382f1bf364928 with license number 2023/172and contains active ingredient Klaritromisin. The license is held by DEVA HOLDİNG A.Ş..

This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
21,000+ Products
64cf9bcffd9cc09db16382f1bf364928
License Details
Turkey SFDA License: 64cf9bcffd9cc09db16382f1bf364928
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Product Details

Declarite 500 mg I.V. Lyophilized Powder and Solvent for Preparing Solution for Infusion, 1 vial + 1 solvent ampoule
TR: Deklarit 500 mg I.V. İnfüzyonluk Çözelti Hazırlamak İçin Liyofilize Toz ve Çözücü, 1 flakon+1 çözücü ampul
Pharmaceutical Product

License Details

64cf9bcffd9cc09db16382f1bf364928

2023/172

8699525798565

J01FA09

License Holder Information

Active Ingredient

Klaritromisin

License Information

May 12, 2023